A national genetic screening program (BRCA1/2 variant founder-mutation panel) is being offered to manage the burden of BC among Bahamian women resulting from several studies that have discovered a high prevalence of BRCA1/2 founder mutations among unselected affected BC persons in addition to unaffected women with a family history of breast and ovarian cancer [53,60,88,89]. This evidence concerns the gene BRCA1 and ovarian carcinoma.